InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+20.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Kanovsky Stephen M, 董事. Director active across 1 company, notably Neogenomics INC. Cumulatively, 5 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €28k. Activity tracked since 2 June 2021. The latest transaction was filed on 1 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kanovsky Stephen M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
12,254 股0Common StockSEC:0001077183-25-000129:0
4,000 股@ US$7.7811100.0% 占其流量Common StockSEC:0001077183-25-000098:0
标准退出：2025年8月5日 (T+90)
11,336 股0Common StockSEC:0001077183-24-000129:0
15,556 股0Common StockSEC:0001077183-22-000112:0
3,081 股0Common StockSEC:0001077183-21-000156:0
5 条申报中的 5 条
About Kanovsky Stephen M
Stephen M. Kanovsky is a Director at Neogenomics Inc. In this role, he contributes to corporate governance and the company's strategy. His experience in the biotechnology sector allows him to provide valuable insights to strategic discussions within the board.
